Parkinson's Disease in the United States: Market Outlook to 2024

Dublin, June 26, 2019 (GLOBE NEWSWIRE) -- The "Parkinson's Disease in the United States: Market Outlook to 2024" report has been added to ResearchAndMarkets.com's offering.

This latest research provides comprehensive insights into Parkinson's Disease pipeline products, Parkinson's Disease epidemiology, Parkinson's Disease market valuations and forecast, Parkinson's Disease drugs sales and competitive landscape in the US.

The research is classified into seven sections - Parkinson's Disease treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

• Parkinson's Disease pipeline: Find out the products in clinical trials for the treatment of Parkinson's Disease by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
• Parkinson's Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Parkinson's Disease in the US
• Parkinson's Disease drugs: Identify key products marketed and prescribed for Parkinson's Disease in the US, including trade name, molecule name, and company
• Parkinson's Disease drugs sales: Find out the sales revenues of Parkinson's Disease drugs in the US
• Parkinson's Disease market valuations: Find out the market size for Parkinson's Disease drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
• Parkinson's Disease drugs market share: Find out the market shares for key Parkinson's Disease drugs in the US

Benefits of this Research

• Support monitoring and reporting national Parkinson's Disease market analysis and sales trends
• Track competitor drugs sales and market share in the US Parkinson's Disease market
• Track competitive developments in Parkinson's Disease market and present key issues and learnings
• Synthesize insights for Parkinson's Disease market and products to drive business performance
• Answer key business questions about the Parkinson's Disease market
• Evaluate commercial market opportunity assessment, positioning, and segmentation for Parkinson's Disease products
• Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Parkinson's Disease Treatments
2) Parkinson's Disease Pipeline
3) US Parkinson's Disease Epidemiology
4) Marketed Drugs for Parkinson's Disease in US
5) US Parkinson's Disease Market Size and Forecast
6) US Parkinson's Disease Products Sales and Forecast
7) US Parkinson's Disease Market Competitive Landscape
8) Methodology

List of Tables
1. Parkinson's Disease Phase 3 Clinical Trials, 2019
2. Parkinson's Disease Phase 2 Clinical Trials, 2019
3. Parkinson's Disease Phase 1 Clinical Trials, 2019
4. Parkinson's Disease Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Parkinson's Disease, US, 2018
6. Parkinson's Disease Market Size and Forecast ($), US, 2014 - 2024
7. Parkinson's Disease Product Sales ($), US, 2014 - 2024

List of Figures
1. Parkinson's Disease Epidemiology, US, 2014 - 2024
2. Parkinson's Disease Market Size and Forecast ($), US, 2014 - 2024
3. Parkinson's Disease Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/7dhhck

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: 
CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs